Business Context and Reporting Period
Company: HC2 Holdings, Inc. (Note: Input metadata referenced "INNOVATE Corp.", but the filing text identifies the registrant as HC2 Holdings, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: July 1, 2021
Event: Entry into a Material Definitive Agreement and Unregistered Sales of Equity Securities in connection with the sale of the subsidiary Continental Insurance Group, Ltd. to Continental General Holdings LLC.
Key Financial Metrics
This filing is a Current Report (8-K) and does not contain audited financial statements, revenue, profit, cash flow, or liquidity metrics. The filing focuses on the terms of a capital restructuring.
- Dividend Rate (New Preferred Stock): 7.50% annualized cumulative quarterly cash dividend.
- Accretion Rate: 4.00% annualized (reducible to 2.00% or 0.00% based on net asset value growth; increases to 7.25% under specific distress conditions).
- Redemption Price (Company Option): Generally 150% of accrued value plus accrued dividends.
- Maturity Date: July 1, 2026.
Material Changes Versus Prior Period
The filing details a significant restructuring of the company's capital structure following the sale of a major subsidiary:
- Preferred Stock Exchange: Existing Series A and Series A-2 Convertible Participating Preferred Stock were exchanged for new Series A-3 and Series A-4 Convertible Participating Preferred Stock.
- Terms Modification: While terms are substantially similar to the existing stock, the new series mature on July 1, 2026. A cash payment was made to settle accrued and unpaid dividends on the exchanged stock.
- Subsidiary Preferred Stock Amendment: The Certificate of Designation for DBM Global Intermediate Holdco Inc. Series A Preferred Stock was amended to redesignate it as "Series A Fixed-to-Floating Rate Redeemable Preferred Stock," granting holders the right to require redemption by July 1, 2026, and allowing payment-in-kind dividends.
Guidance, Outlook, and Risks
Management Commentary: The restructuring was executed in connection with the previously announced sale of the Continental Insurance Group subsidiary.
Risks and Contingencies:
- Liquidity and Redemption Risk: Holders can force redemption on July 1, 2026, or upon a change of control. The Company may be forced to redeem at 150% of accrued value if it exercises its redemption option.
- Dividend Escalation: The accretion rate increases to 7.25% if the Common Stock's daily VWAP falls below a threshold, if the stock is delisted, or if the Company is delinquent on cash dividends.
- Forced Conversion: The Company may force conversion to Common Stock if the 30-day VWAP exceeds 150% of the conversion price for 20 out of 30 trading days.
- Registration Rights: Holders of the new preferred stock have significant registration rights, obligating the Company to file registration statements (Form S-1 or S-3) within 30 days of request.
Investor Verification Checklist
- Verify the exact number of shares exchanged and the total cash payment made for accrued dividends (specific figures not provided in this summary text).
- Review the attached Certificates of Designation (Exhibits 4.1 and 4.2) for the specific "threshold amount" that triggers the 7.25% accretion rate.
- Confirm the impact of the subsidiary sale on the Company's remaining net asset value and ability to meet the 4.00% accretion reduction criteria.
- Assess the Company's liquidity position to determine its ability to fund potential redemptions at 150% of accrued value in 2026.
- Check the status of the Common Stock listing and VWAP to evaluate the risk of forced conversion or dividend rate escalation.